Cargando…

Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study

BACKGROUND: Factor V G1691A (FV Leiden), FII GA20210, and methylenetetrahydrofolate reductase (MTHFR) C677T mutations are the most common genetic risk factors for thromboembolism in the Western countries. However, there is rare data in Iran about cerebral venous and sinus thrombosis (CVST) patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Saadatnia, Mohammad, Salehi, Mansour, Movahedian, Ahmad, Shariat, Seyed Ziaeddin Samsam, Salari, Mehri, Tajmirriahi, Marzieh, Asadimobarakeh, Elham, Salehi, Rasoul, Amini, Gilda, Ebrahimi, Homa, Kheradmand, Ehsan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621649/ https://www.ncbi.nlm.nih.gov/pubmed/26600830 http://dx.doi.org/10.4103/1735-1995.165956

Ejemplares similares

Polymorphisms at activated protein C cleavage sites of factor V: Are they important in the absence of factor V Leiden?
por: Kheradmand, Ehsan, et al.
Publicado: (2017)

Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients
por: Akın, Dilara Fatma, et al.
Publicado: (2012)

Direct‐to‐consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
por: Elson, Sarah L., et al.
Publicado: (2020)

Factor V Leiden does not have a role in cryptogenic ischemic stroke among Iranian young adults
por: Kheradmand, Ehsan, et al.
Publicado: (2014)

Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
por: Padda, Jaskamal, et al.
Publicado: (2021)

Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss
por: Teremmahi Ardestani, Majid, et al.
Publicado: (2013)

Acute Myocardial Infarction in Patients with Hereditary Thrombophilia—A Focus on Factor V Leiden and Prothrombin G20210A
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
por: Machado, Marcia, et al.
Publicado: (2023)

The impact of prothrombin (G20210A) gene mutation on stroke in youths
por: Saadatnia, Mohammad, et al.
Publicado: (2012)

Risk of Budd-Chiari Syndrome Associated with Factor V Leiden and G20210A Prothrombin Mutation: A Meta-Analysis
por: Zhang, Peijin, et al.
Publicado: (2014)

Association of Factor V Leiden and Prothrombin G20210A Polymorphisms in Women with Recurrent Pregnancy Loss in Isfahan Province, Iran
por: Kardi, Mohammad Taghi, et al.
Publicado: (2018)

The Role of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T Mutations in Neonatal Cerebral Sinovenous Thrombosis
por: Garrido-Barbero, Maria, et al.
Publicado: (2019)

Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients
por: El-Ghonemy, Mohamed S., et al.
Publicado: (2020)

Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease
por: Samarah, Fekri, et al.
Publicado: (2018)

Papillophlebitis Associated With Coexisting Heterozygous Mutations of Factor V Leiden and Methylenetetrahydrofolate Reductase Enzyme-(C677T)
por: Ntora, Efthalia, et al.
Publicado: (2021)

Factor V Leiden but not the factor II 20210G>A mutation is a risk factor for premature coronary artery disease: a case-control study in Iran
por: Agosti, Pasquale, et al.
Publicado: (2023)

Factor-V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with preeclampsia, a case -control study
por: Ahmed, Nadir A., et al.
Publicado: (2019)

Factor V Leiden and Inflammation
por: Perez-Pujol, Silvia, et al.
Publicado: (2012)

Large‐scale screening for factor V Leiden (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in Greek population
por: Raptopoulou, Alkistis, et al.
Publicado: (2022)

Investigation of methylenetetrahydrofolate reductase C677T and factor V Leiden mutation as a genetic marker for retinal vein occlusion
por: Nema, Nitin, et al.
Publicado: (2018)

PlA2 Polymorphism of Platelet Glycoprotein IIb/IIIa and C677T Polymorphism of Methylenetetrahydrofolate Reductase (MTHFR), but Not Factor V Leiden and Prothrombin G20210A Polymorphisms, Are Associated with More Severe Forms of Legg–Calvé–Perthes Disease
por: García-Alfaro, María Dolores, et al.
Publicado: (2021)

MTHFR C677T, Prothrombin G20210A, and Factor V Leiden (G1691A) Polymorphism and Beta-Thalassemia Risk: A Meta-Analysis
por: Nigam, Nitu, et al.
Publicado: (2020)

Electrocardiographic changes in patients with refractory epilepsy
por: Zare, Mohammad, et al.
Publicado: (2013)

Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
por: John-Olabode, Sarah O, et al.
Publicado: (2021)

Association between Polymorphism eNOS4, tPA, Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase and the Occurrence of Legg–Calvé–Perthes Disease
por: Matuszewska, Anna, et al.
Publicado: (2023)

Perioperative Management of Factor V Leiden and Pancreatic Adenocarcinoma
por: O'Malley, Thomas J., et al.
Publicado: (2017)

Factor V Leiden interferes with protein S activity assay
por: Panaget, Baptiste, et al.
Publicado: (2023)

Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrome in a Caucasian Population
por: D'Amico, Mario, et al.
Publicado: (2013)

The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke
por: Pirhoushiaran, Maryam, et al.
Publicado: (2014)

Myotonic Dystrophy-1 Complicated by Factor-V (Leiden) Mutation
por: Finsterer, Josef, et al.
Publicado: (2015)

Combination of factor V Leiden and MTHFR mutations in myocardial infarction
por: Fekih-Mrissa, Najiba, et al.
Publicado: (2013)

Sclerosing Mesenteritis in a Patient Heterozygous for Factor V Leiden
por: Reddington, Hayley, et al.
Publicado: (2020)

Effects of factor v Leiden polymorphism on the pathogenesis and outcomes of preeclampsia
por: Ababio, G. K., et al.
Publicado: (2019)

Pulmonary Embolism in a Sarcoidosis Patient Double Heterozygous for Methylenetetrahydrofolate Reductase Gene Polymorphisms and Factor V Leiden and Homozygous for the D-Allele of Angiotensin Converting Enzyme Gene
por: El-Majzoub, Nadim, et al.
Publicado: (2015)

Is there a relationship between factor V Leiden and type 2 diabetes?
por: Lodigiani, Corrado, et al.
Publicado: (2009)

Possible impact of factor V Leiden genotype on warfarin induced bleeding
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Factor V Leiden mutation: An added risk in single ventricle palliation
por: Saileela, R, et al.
Publicado: (2012)

Multiple Brain Abscesses in an Immunocompetent Patient With Factor V Leiden Mutation
por: Zafar, Saeed Zubair, et al.
Publicado: (2016)

Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population
por: Yıldız, Eray, et al.
Publicado: (2020)

Homozygous factor V leiden mutation: Rare etiology of pulmonary embolism
por: el marraki, Zakaria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ktc28tg27r98uru4dabna855ng